Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
UNIVERSITE DE PARIS currently has 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. These 2 pending office actions are being reviewed by 2 distinct examiners, which suggests that each active application is receiving a unique perspective from the USPTO. Despite the involvement of multiple examiners, the entire pending portfolio is situated within 1 distinct art unit, providing a centralized technical environment for these life sciences matters.
The busiest examiner for the university is GIAMMONA, FRANCESCA FILIPPA, who is responsible for 1 busiest examiner pending office action. With 2 distinct examiners involved in the 2 pending office actions, the workload is distributed, meaning no single examiner dominates the current prosecution landscape. This distribution requires the applicant to adapt to the specific nuances of GIAMMONA, FRANCESCA FILIPPA while simultaneously managing a separate set of requirements from the other examiner.
The concentration of all activity in 1 distinct art unit is a significant factor for the Biotechnology & Pharmaceuticals filings. It implies that the technical subject matter is closely related, even if the 2 distinct examiners bring different levels of scrutiny to the applications. Practitioners should focus on the specific tendencies of GIAMMONA, FRANCESCA FILIPPA to resolve the 1 busiest examiner pending office action, while monitoring the single art unit for broader trends in pharmaceutical examination.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GIAMMONA, FRANCESCA FILIPPA | 1 | 37.5% | +57.4% |
| YU, TIAN NMN | 1 | 55.1% | +20.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17614023 | METHOD OF DIGITAL MULTIPLEX DETECTION AND/OR QUANTIFICATION OF BIOMOLECULES AND USE THEREOF | GIAMMONA, FRANCESCA FILIPPA | 30d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17614023 | METHOD OF DIGITAL MULTIPLEX DETECTION AND/OR QUANTIFICATION OF BIOMOLECULES AND USE THEREOF | GIAMMONA, FRANCESCA FILIPPA | 30d overdue |
| 17613990 | DIGITAL BIOMOLECULES DETECTION AND/OR QUANTIFICATION USING ISOTHERMAL AMPLIFICATION | YU, TIAN NMN | — |
| Art Unit | Apps |
|---|---|
| 1681 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17614023 | METHOD OF DIGITAL MULTIPLEX DETECTION AND/OR QUANTIFICATION OF BIOMOLECULES AND USE THEREOF | GIAMMONA, FRANCESCA FILIPPA | 1681 | §103§112 | Final Rejection | 30d overdue | Pending | Nov 24, 2021 |
| 17613990 | DIGITAL BIOMOLECULES DETECTION AND/OR QUANTIFICATION USING ISOTHERMAL AMPLIFICATION | YU, TIAN NMN | 1681 | §103§112DP | Final Rejection | — | Pending | Nov 24, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial